166 results on '"Rosenberg, Shai"'
Search Results
2. Cancer associated variant enrichment CAVE, a gene agnostic approach to identify low burden variants in chronic lymphocytic leukemia
3. Multimodal Machine Learning for Prediction of 30-Day Readmission Risk in Elderly Population
4. Cancer mutational signatures identification in clinical assays using neural embedding-based representations
5. Both cell autonomous and non-autonomous processes modulate the association between replication timing and mutation rate
6. Mutational signatures association with replication timing in normal cells reveals similarities and differences with matched cancer tissues
7. Distinct breast cancer phenotypes in BRCA 1/2 carriers based on ER status
8. Survival Implications of the Relationship between Tissue versus Circulating Tumor DNA TP53 Mutations—A Perspective from a Real-World Precision Medicine Cohort
9. Infinite closed monochromatic subsets of a metric space
10. Square-free values of multivariate polynomials over function fields in linear sparse sets
11. EXTH-59. IDENTIFICATION OF GROWTH HORMONE RECEPTOR AS A RELEVANT TARGET FOR PRECISION MEDICINE IN LOW-EGFR EXPRESSING GLIOBLASTOMA
12. Comprehensive assessment of TP53 loss of function using multiple combinatorial mutagenesis libraries
13. Evidence for Positive Selection and Population Structure at the Human MAO-A Gene
14. ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma
15. Neurologic complications of immune checkpoint inhibitors
16. Both cell autonomous and non-autonomous processes modulate the association between replication timing and mutation rate
17. Data from Survival Implications of the Relationship between Tissue versus Circulating Tumor DNA TP53 Mutations—A Perspective from a Real-World Precision Medicine Cohort
18. Supplementary Tables from Survival Implications of the Relationship between Tissue versus Circulating Tumor DNA TP53 Mutations—A Perspective from a Real-World Precision Medicine Cohort
19. Data from Cancer Mutational Processes Vary in Their Association with Replication Timing and Chromatin Accessibility
20. Table S7 from Shared Cancer Dataset Analysis Identifies and Predicts the Quantitative Effects of Pan-Cancer Somatic Driver Variants
21. Supplementary Data from Cancer Mutational Processes Vary in Their Association with Replication Timing and Chromatin Accessibility
22. Supplementary Data from Shared Cancer Dataset Analysis Identifies and Predicts the Quantitative Effects of Pan-Cancer Somatic Driver Variants
23. Concordance between cancer gene alterations in tumor and circulating tumor DNA correlates with poor survival in a real‐world precision‐medicine population.
24. Same-day genomic and epigenomic diagnosis of brain tumors using real-time nanopore sequencing
25. Shared Cancer Dataset Analysis Identifies and Predicts the Quantitative Effects of Pan-Cancer Somatic Driver Variants
26. Both cell autonomous and non-autonomous processes modulate the association between replication timing and mutation rate
27. Identification of growth hormone receptor as a relevant target for precision medicine in low‐EGFR expressing glioblastoma
28. High throughput SARS-CoV-2 variant analysis using molecular barcodes coupled with next generation sequencing
29. Tumor cells with neuronal intermediate progenitor features define a subgroup of 1p/19q co‐deleted anaplastic gliomas
30. Increased High-Sensitivity Troponin-T Levels Are Associated with Mortality After Ischemic Stroke
31. Rituximab, methotrexate, procarbazine and lomustine (R-MPL) for the treatment of primary Central nervous system lymphoma
32. TP53_PROF: a machine learning model to predict impact of missense mutations in TP53
33. Cancer Mutational Processes Vary in Their Association with Replication Timing and Chromatin Accessibility
34. Correction to: ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma
35. High throughput SARS-CoV-2 variant analysis using molecular barcodes coupled with Next Generation Sequencing
36. The association of DNA sequence variation at the MAOA genetic locus with quantitative behavioural traits in normal males
37. Emergent stent-assisted angioplasty of extracranial internal carotid artery and intracranial stent-based thrombectomy in acute tandem occlusive disease: technical considerations
38. EPCO-28. SPHEROID STUDY OF A GLIOBLASTOMA TUMOR IDENTIFIED A SUBCLONAL MUTATION OF EGFR T790M
39. High prevalence of cancer‐associated TP53 variants in the gnomAD database: A word of caution concerning the use of variant filtering
40. A recurrent point mutation in PRKCA is a hallmark of chordoid gliomas
41. Ev vivo organ culture as potential prioritization tool for breast cancer targeted therapy
42. Tumor cells with neuronal intermediate progenitor features define a subgroup of 1p/19q co-deleted anaplastic gliomas
43. GENE-54. A NOVEL MUTATION IN PRKCA IS THE MAJOR DRIVER OF CHORDOID GLIOMAS
44. NTOX-13. NEUROLOGIC COMPLICATIONS OF IMMUNE CHECKPOINT INHIBITORS
45. Treatment inferred from mutations identified using massive parallel sequencing leads to clinical benefit in some heavily pretreated cancer patients
46. Machine Learning for Better Prognostic Stratification and Driver Gene Identification Using Somatic Copy Number Variations in Anaplastic Oligodendroglioma.
47. Square-free values of multivariate polynomials over function fields in linear sparse sets
48. Multi-omics analysis of primary glioblastoma cell lines shows recapitulation of pivotal molecular features of parental tumors
49. GENO-33PATIENT DERIVED GLIOBLASTOMA CELL LINES RECAPITULATE PARENTAL TUMORS' MOLECULAR LANDSCAPE
50. Square-free values of multivariate polynomials over function fields in linear sparse sets.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.